Tigecycline for treatment of carbapenem-resistant Klebsiella pneumoniae infections after liver transplantation in the intensive care unit: a 3-year study.

[1]  M. Bartels,et al.  Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case–control analysis , 2014, Infection.

[2]  M. Falagas,et al.  Antibiotic Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae: Systematic Evaluation of the Available Evidence , 2013, Antimicrobial Agents and Chemotherapy.

[3]  W. Heizmann,et al.  Therapy of 1,025 Severely Ill Patients with Complicated Infections in a German Multicenter Study: Safety Profile and Efficacy of Tigecycline in Different Treatment Modalities , 2012, Chemotherapy.

[4]  G. Daikos,et al.  Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions , 2012, Clinical Microbiology Reviews.

[5]  T. Schiano,et al.  Mortality associated with carbapenem‐resistant Klebsiella pneumoniae infections in liver transplant recipients , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[6]  D. O. Garcia,et al.  Infection with Klebsiella pneumoniae carbapenemase (KPC)‐producing K. pneumoniae in solid organ transplantation , 2012, Transplant infectious disease : an official journal of the Transplantation Society.

[7]  M. Rela,et al.  Mortality associated with carbapenem‐resistant Klebsiella pneumoniae infections in liver transplant recipients , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[8]  R. Guner,et al.  Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy , 2011, Infection.

[9]  E. Roilides,et al.  Bloodstream Infections Caused by Metallo-β-Lactamase/Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae among Intensive Care Unit Patients in Greece: Risk Factors for Infection and Impact of Type of Resistance on Outcomes , 2010, Infection Control & Hospital Epidemiology.

[10]  Arthur J. L. Cooper,et al.  Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trials. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Gopi Patel,et al.  Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies , 2008, Infection Control & Hospital Epidemiology.